Corporate Profile

SeaStar Medical is a publicly traded medical technology company that is redefining how extracorporeal therapies can reduce the consequences of excessive inflammation on vital organs through novel solutions and services. Our focus is on transforming key immune system messengers from pro-inflammatory to reparative physiology or removing pro-inflammatory mediators, known as cytokines. The impact of inflammation on organs and long-term health is just beginning to be understood. We have studied the market, assembled the experts to research the science and evaluated the opportunity.

With a new management team, fresh focus and innovative products in development, we invite you to get to know today’s SeaStar Medical.